Eulexin
Formulated to target prostate cancer to alleviate hormonal progression.
Strengths: 250mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Anti-Androgen
- Pharmacological class
Non-steroidal Anti-androgen
- Contraindications
severe hepatic impairment; hypersensitivity
- Precautions and warnings
monitor liver enzymes; monitor blood counts; discontinue if jaundice observed
- Minor side effects
hot flushes; nausea; diarrhoea
- Moderate side effects
gynaecomastia; decreased libido; fatigue
- Dosage forms
Tablet
- Administration route
Oral use
- Patient summary
Formulated to target prostate cancer to alleviate hormonal progression.
- Prescription status
POM
- Manufacturer
Schering-Plough
- Onset Time
varies
- Duration
long-term
- Storage instructions
Store in original container at room temperature.
- Drug interactions
Warfarin
- Age restrictions
Adults only.
- Pregnancy and breastfeeding
Not indicated for women.
Serious side effects
liver failure — requires immediate medical attention; hepatitis — requires immediate medical attention
Mechanism of action
A non-steroidal anti-androgen that competes with testosterone for receptor sites in the prostate, thus preventing cancer cell growth driven by androgens.
Eulexin
Formulated to target prostate cancer to alleviate hormonal progression.
Editorial Notes
- Active ingredient(s): Flutamide
- Listed indication(s): Prostate Cancer
Available option
- 60 tablets - 250 mg274-250-mg-2912